Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 6;5(1):1-8.
doi: 10.1007/s12177-012-9091-0. Print 2012 Mar.

Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy

Affiliations

Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy

Ghulam Mohammad et al. J Ocul Biol Dis Infor. .

Abstract

Diabetic retinopathy represents the most common causes of vision loss in patients affected by diabetes mellitus. The cause of vision loss in diabetic retinopathy is complex and remains incompletely understood. One of the earliest changes in the development of retinopathy is the accelerated apoptosis of retinal microvascular cells and the formation of acellular capillaries by unknown mechanism. Results of a recent research suggest an important role of matrix metalloproteinases (MMPs) in the development of diabetic retinopathy. MMPs are a large family of proteinases that remodel extracellular matrix components, and under pathological condition, its induction is considered as a negative regulator of cell survival; and in diabetes, latent MMPs are activated in the retina and its capillary cells, and activation of MMP-2 and -9 induces apoptosis of retinal capillary cells. This review will focus on the MMP-2 and MMP-9 in the diabetic retina with special reference to oxidative stress, mitochondria dysfunction, inflammation and angiogenesis, as well as summarizing the current information linking these proteins to pathogenesis of diabetic retinopathy.

Keywords: Angiogenesis; Apoptosis; Diabetic retinopathy; Inflammation; MMP-2; MMP-9; Oxidative stress.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Klein R. Diabetic retinopathy. Annu Rev Public Health. 1996;17:137–158. - PubMed
    1. Kalfa TA, Gerritsen ME, Carlson EC, Binstock AJ, Tsilibary EC. Altered proliferation of retinal microvascular cells on glycated matrix. Invest Ophthalmol Vis Sci. 1995;36:2358–2367. - PubMed
    1. Dosso AA, Leuenberger PM, Rungger-Brändle E. Remodeling of retinal capillaries in the diabetic hypertensive rat. Invest Ophthalmol Vis Sci. 1999;40:2405–2410. - PubMed
    1. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 2002;16:242–260. - PubMed
    1. Simó R, Carrasco E, García-Ramírez M, Hernández C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev. 2006;2:71–98. - PubMed

LinkOut - more resources